SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-244495
Filing Date
2019-09-13
Accepted
2019-09-13 09:01:33
Documents
4
Period of Report
2019-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d804745d8k.htm 8-K 26009
2 EX-4.1 d804745dex41.htm EX-4.1 59203
3 EX-10.1 d804745dex101.htm EX-10.1 117061
4 EX-10.2 d804745dex102.htm EX-10.2 136779
  Complete submission text file 0001193125-19-244495.txt   340415
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 191091602
SIC: 2834 Pharmaceutical Preparations